Company intelligence / Profile preview

APIK

Edmonton, Alberta, Canadaapi-k.com ↗

Ownership: Private
Development stage: Commercial

Overview

API is one of Canada’s largest not-for-profit life sciences commercialization organizations. It provides technical and scientific capacity to help life science companies translate research into commercial products. The organization supports more than 75 commercial projects and has created over $700M in value for the Canadian life sciences sector. It does not develop its own clinical-stage drugs but enables others’ progress from preclinical through commercialization.

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: Small moleculeBiologicMedical deviceDiagnostic technologyNatural health product
Industry: Contract Manufacturing Organization

Partnerships

Canadian Critical Drug Initiative (CCDI)Collaborations with academic institutions and industry partners across Canada

Beyond the preview

Go deeper on APIK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on APIK.

Explore the full profile